Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

Screening for latent TB, HIV, and hepatitis B/C in new migrants in a high prevalence area of London, UK: a cross-sectional study

Authors: Sally Hargreaves, Farah Seedat, Josip Car, Rod Escombe, Samia Hasan, Joseph Eliahoo, Jon S Friedland

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

Rising rates of infectious diseases in international migrants has reignited the debate around screening. There have been calls to strengthen primary-care-based programmes, focusing on latent TB. We did a cross-sectional study of new migrants to test an innovative one-stop blood test approach to detect multiple infections at one appointment (HIV, latent tuberculosis, and hepatitis B/C) on registration with a General Practitioner (GP) in primary care.

Methods

The study was done across two GP practices attached to hospital Accident and Emergency Departments (A&E) in a high migrant area of London for 6 months. Inclusion criteria were foreign-born individuals from a high TB prevalence country (>40 cases per 100,000) who have lived in the UK ≤ 10 years, and were over 18 years of age. All new migrants who attended a New Patient Health Check were screened for eligibility and offered the blood test. We followed routine care pathways for follow-up.

Results

There were 1235 new registrations in 6 months. 453 attended their New Patient Health Check, of which 47 (10.4%) were identified as new migrants (age 32.11 years [range 18–72]; 22 different nationalities; time in UK 2.28 years [0–10]). 36 (76.6%) participated in the study. The intervention only increased the prevalence of diagnosed latent TB (18.18% [95% CI 6.98-35.46]; 181.8 cases per 1000). Ultimately 0 (0%) of 6 patients with latent TB went on to complete treatment (3 did not attend referral). No cases of HIV or hepatitis B/C were found. Foreign-born patients were under-represented at these practices in relation to 2011 Census data (Chi-square test −0.111 [95% CI −0.125 to −0.097]; p < 0.001).

Conclusion

The one-stop approach was feasible in this context and acceptability was high. However, the number of presenting migrants was surprisingly low, reflecting the barriers to care that this group face on arrival, and none ultimately received treatment. The ongoing UK debate around immigration checks and charging in primary care for new migrants can only have negative implications for the promotion of screening in this group. Until GP registration is more actively promoted in new migrants, a better place to test this one-stop approach could be in A&E departments where migrants may present in larger numbers.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rechel B, Mladovsky P, Ingleby D, Mackenbach JP, McKee M: Migration and health in an increasingly diverse Europe. Lancet. 2013, 381 (9873): 1235-1245. 10.1016/S0140-6736(12)62086-8.CrossRefPubMed Rechel B, Mladovsky P, Ingleby D, Mackenbach JP, McKee M: Migration and health in an increasingly diverse Europe. Lancet. 2013, 381 (9873): 1235-1245. 10.1016/S0140-6736(12)62086-8.CrossRefPubMed
2.
go back to reference Hargreaves S, Friedland JS: Impact On and Use of Health Services by New Migrants in Europe. Migration, Health and Inequality. Edited by: Thomas F, Gideon J. 2013, Zed Books, London Hargreaves S, Friedland JS: Impact On and Use of Health Services by New Migrants in Europe. Migration, Health and Inequality. Edited by: Thomas F, Gideon J. 2013, Zed Books, London
3.
go back to reference Migrant Health: Infectious Diseases in Non-UK Born Populations in England, Wales, and Northern Ireland. An Update to the Baseline Report - 2011. 2011, Health Protection Agency Centre for Infections, London Migrant Health: Infectious Diseases in Non-UK Born Populations in England, Wales, and Northern Ireland. An Update to the Baseline Report - 2011. 2011, Health Protection Agency Centre for Infections, London
4.
go back to reference Tuberculosis in the UK: Annual Report on Tuberculosis Surveillance in the UK, 2013. 2013, Public Health England, London Tuberculosis in the UK: Annual Report on Tuberculosis Surveillance in the UK, 2013. 2013, Public Health England, London
5.
go back to reference Tuberculosis Surveillance and Monitoring in Europe 2013. 2013, ECDC, Stockholm Tuberculosis Surveillance and Monitoring in Europe 2013. 2013, ECDC, Stockholm
6.
go back to reference Hahne SJM, Veldhuijzen IK, Wiessing L, Lim T-A, Salminen M, van de Laar M: Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis. 2013, 13: 181-10.1186/1471-2334-13-181.CrossRefPubMedPubMedCentral Hahne SJM, Veldhuijzen IK, Wiessing L, Lim T-A, Salminen M, van de Laar M: Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis. 2013, 13: 181-10.1186/1471-2334-13-181.CrossRefPubMedPubMedCentral
7.
go back to reference Hargreaves S, Carballo M, Friedland JS: Screening migrants for tuberculosis - where next?. Lancet Infect Dis. 2009, 9: 139-140. 10.1016/S1473-3099(09)70026-X.CrossRefPubMed Hargreaves S, Carballo M, Friedland JS: Screening migrants for tuberculosis - where next?. Lancet Infect Dis. 2009, 9: 139-140. 10.1016/S1473-3099(09)70026-X.CrossRefPubMed
8.
go back to reference Bothamley GH, Rowan JP, Griffiths CJ, Beeks M, McDonald M, Beasley E, van den Bosch C, Feder G: Screening for tuberculosis: the port of arrival scheme compared with screening in general practice and the homeless. Thorax. 2002, 57: 45-49. 10.1136/thorax.57.1.45.CrossRefPubMedPubMedCentral Bothamley GH, Rowan JP, Griffiths CJ, Beeks M, McDonald M, Beasley E, van den Bosch C, Feder G: Screening for tuberculosis: the port of arrival scheme compared with screening in general practice and the homeless. Thorax. 2002, 57: 45-49. 10.1136/thorax.57.1.45.CrossRefPubMedPubMedCentral
9.
go back to reference Ormerod LP: Further evidence supporting programmatic screening for, and treatment of latent TB Infection (LTBI) in new entrants to the UK from high TB prevalence countries. Thorax. 2013, 68: 201-10.1136/thoraxjnl-2012-202184.CrossRefPubMed Ormerod LP: Further evidence supporting programmatic screening for, and treatment of latent TB Infection (LTBI) in new entrants to the UK from high TB prevalence countries. Thorax. 2013, 68: 201-10.1136/thoraxjnl-2012-202184.CrossRefPubMed
10.
go back to reference Pareek M: Evaluation of immigrant tuberculosis screening in industrialize countries. Emerg Infect Dis. 2012, 18 (9): 1422-1429. 10.3201/eid1809.120128.CrossRefPubMedPubMedCentral Pareek M: Evaluation of immigrant tuberculosis screening in industrialize countries. Emerg Infect Dis. 2012, 18 (9): 1422-1429. 10.3201/eid1809.120128.CrossRefPubMedPubMedCentral
11.
go back to reference Pareek M, Watson JP, Ormerod LP, Kon OM, Woltmann G, White PJ, Abubakar I, Lalvani A: Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet. 2011, 11: 435-444. 10.1016/S1473-3099(11)70069-X.CrossRefPubMedPubMedCentral Pareek M, Watson JP, Ormerod LP, Kon OM, Woltmann G, White PJ, Abubakar I, Lalvani A: Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet. 2011, 11: 435-444. 10.1016/S1473-3099(11)70069-X.CrossRefPubMedPubMedCentral
12.
go back to reference Pareek M: Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice. Eur Respir J. 2011, 37 (5): 1175-1182. 10.1183/09031936.00105810.CrossRefPubMed Pareek M: Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice. Eur Respir J. 2011, 37 (5): 1175-1182. 10.1183/09031936.00105810.CrossRefPubMed
13.
go back to reference Veldhuijzen IK, Toy M, Hahne SJM, de Wit GA, Richardus JH: Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective. Gastroenterology. 2010, 13 (2): 522-530. 10.1053/j.gastro.2009.10.039.CrossRef Veldhuijzen IK, Toy M, Hahne SJM, de Wit GA, Richardus JH: Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective. Gastroenterology. 2010, 13 (2): 522-530. 10.1053/j.gastro.2009.10.039.CrossRef
14.
go back to reference Increasing the Uptake of HIV Testing Among Black Africans in England. 2011, NICE, London Increasing the Uptake of HIV Testing Among Black Africans in England. 2011, NICE, London
15.
go back to reference Collaborative TB Strategy for England: 2014–2019. For Consultation. 2014, PHE, London Collaborative TB Strategy for England: 2014–2019. For Consultation. 2014, PHE, London
16.
go back to reference Quantitative Assessment of Visitor and Migrant Use of the NHS in England. Exploring the Data. Summary Report. 2013, Prederi, London Quantitative Assessment of Visitor and Migrant Use of the NHS in England. Exploring the Data. Summary Report. 2013, Prederi, London
17.
go back to reference Stagg HR, Jones J, Bickler G, Abubakar I: Poor uptake of primary healthcare registration among recent entrants to the UK: a retrospective cohort study. BMJ Open. 2012, 2: e001453-10.1136/bmjopen-2012-001453. doi: 10.1136/bmjopen-2012-001453CrossRefPubMedPubMedCentral Stagg HR, Jones J, Bickler G, Abubakar I: Poor uptake of primary healthcare registration among recent entrants to the UK: a retrospective cohort study. BMJ Open. 2012, 2: e001453-10.1136/bmjopen-2012-001453. doi: 10.1136/bmjopen-2012-001453CrossRefPubMedPubMedCentral
18.
go back to reference Hargreaves S, Holmes AH, Saxena S, Eliahoo J, Friedland JS: Charging systems for migrants in primary care: the experiences of family doctors in a high-migrant area of London. J Travel Med. 2008, 15: 13-18. 10.1111/j.1708-8305.2007.00161.x.CrossRefPubMed Hargreaves S, Holmes AH, Saxena S, Eliahoo J, Friedland JS: Charging systems for migrants in primary care: the experiences of family doctors in a high-migrant area of London. J Travel Med. 2008, 15: 13-18. 10.1111/j.1708-8305.2007.00161.x.CrossRefPubMed
19.
go back to reference Census: Aggregate Data (England and Wales). 2011 Census: Aggregate Data (England and Wales). 2011
20.
go back to reference Griffiths C, Sturdy P, Brewin P, Bothamley G, Eldridge S, Martineau A, MacDonald M, Ramsay J, Tibrewal S, Levi S, Zumla A, Feder G: Educational outreach to promote screening for tuberculosis in in primary care: a cluster randomised controlled trial. Lancet. 2007, 369 (9572): 1528-1534. 10.1016/S0140-6736(07)60707-7.CrossRefPubMed Griffiths C, Sturdy P, Brewin P, Bothamley G, Eldridge S, Martineau A, MacDonald M, Ramsay J, Tibrewal S, Levi S, Zumla A, Feder G: Educational outreach to promote screening for tuberculosis in in primary care: a cluster randomised controlled trial. Lancet. 2007, 369 (9572): 1528-1534. 10.1016/S0140-6736(07)60707-7.CrossRefPubMed
22.
go back to reference Brewin P, Jones A, Kelly M, McDonald M, Beasley E, Sturdy P, Bothamley G, Griffiths C: Is screening for tuberculosis acceptable to immigrants? A qualitative study. J Public Health. 2006, 28: 253-260. 10.1093/pubmed/fdl031.CrossRef Brewin P, Jones A, Kelly M, McDonald M, Beasley E, Sturdy P, Bothamley G, Griffiths C: Is screening for tuberculosis acceptable to immigrants? A qualitative study. J Public Health. 2006, 28: 253-260. 10.1093/pubmed/fdl031.CrossRef
23.
go back to reference Seedat F, Hargreaves S, Friedland JS: Engaging new migrants in infectious disease screening: a qualitative semi-structured in-depth interview study of UK migrant community health-care leads. PLoS One. 2014, 9 (10): e108261-10.1371/journal.pone.0108261. doi:10.1371/journal.pone.0108261CrossRefPubMedPubMedCentral Seedat F, Hargreaves S, Friedland JS: Engaging new migrants in infectious disease screening: a qualitative semi-structured in-depth interview study of UK migrant community health-care leads. PLoS One. 2014, 9 (10): e108261-10.1371/journal.pone.0108261. doi:10.1371/journal.pone.0108261CrossRefPubMedPubMedCentral
24.
go back to reference Thomas F, Aggleton P, Anderson J: “If I cannot access services, then there is no reason for me to test”: the impacts of health service charges on HIV testing and treatment amongst migrants in England. AIDS CARE. 2010, 22 (4): 526-531. 10.1080/09540120903499170.CrossRefPubMed Thomas F, Aggleton P, Anderson J: “If I cannot access services, then there is no reason for me to test”: the impacts of health service charges on HIV testing and treatment amongst migrants in England. AIDS CARE. 2010, 22 (4): 526-531. 10.1080/09540120903499170.CrossRefPubMed
25.
go back to reference Sustaining Services and Ensuring Fairness in the NHS. Implementation Outline. 2014, DoH, London Sustaining Services and Ensuring Fairness in the NHS. Implementation Outline. 2014, DoH, London
26.
go back to reference Hargreaves S, Friedland JS, Gothard P, Saxena S, Millington H, Eliahoo J, Le Feuvre P, Homes A: Impact on and use of health services by international migrants: questionnaire survey of inner city London A&E attenders. BMC Hlth Serv Res. 2006, 6: 153-158. 10.1186/1472-6963-6-153. http://www.biomedcentral.com/1472-6963/6/153CrossRef Hargreaves S, Friedland JS, Gothard P, Saxena S, Millington H, Eliahoo J, Le Feuvre P, Homes A: Impact on and use of health services by international migrants: questionnaire survey of inner city London A&E attenders. BMC Hlth Serv Res. 2006, 6: 153-158. 10.1186/1472-6963-6-153. http://​www.​biomedcentral.​com/​1472-6963/​6/​153CrossRef
Metadata
Title
Screening for latent TB, HIV, and hepatitis B/C in new migrants in a high prevalence area of London, UK: a cross-sectional study
Authors
Sally Hargreaves
Farah Seedat
Josip Car
Rod Escombe
Samia Hasan
Joseph Eliahoo
Jon S Friedland
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-014-0657-2

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.